Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Mini-Lungs In A Dish, Airway Stem Cells, Evolution of Virus Mutations: COVID-19 Updates

    Oct 30, 2020, 10:51 AM by User Not Found
    Bio-IT World I Neutrons chart atomic map of COVID-19’s viral replication, Organs-on-Chips technology, coronaviruses mimic proteins that control blood coagulation and inflammation, therapeutic effects of Chinese herbal medicine, crystal structure identified on SARS-CoV-2 papain-like protease, and potent antibody isolated. Plus: NIH researchers discover key pathway in lysosomes for coronaviruses exit, deep learning models to target SARS-CoV-2 main protease, RBD nanoparticles may be effective vaccine, predicting outbreaks, virus may ‘hide’ in asymptomatic people, and NYC outbreak linked to Europe.
    Full story
  • Dyadic C1 protein expression platform explored in fight against COVID-19

    Oct 30, 2020, 09:51 AM by Abhinav Singh
    JUPITER, FL, UNITED STATES - Oct 30, 2020 - Dyadic International, Inc. (NASDAQ: DYAI) a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced from Dyadic’s industrially proven proprietary & patented hyper-productive C1 gene expression platform
    Full story
  • Muscular Dystrophy Association Launches MOVR Visualization and Reporting Platform to Improve Patient Care and Accelerate Drug Discovery

    Oct 29, 2020, 14:22 PM by Abhinav Singh
    NEW YORK, NY, UNITED STATES - Oct 29, 2020 - The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP)
    Full story
  • Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial

    Oct 29, 2020, 08:27 AM by Abhinav Singh
    AUSTIN, TX - Oct 29, 2020 - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has treated the first patient in the sixth and final cohort of its National Cancer Institute (NCI)-supported, multi-center ReSPECT™ Phase 1 dose-finding clinical trial evaluating Rhenium NanoLiposomes (RNL™) for the treatment of recurrent glioblastoma (GBM)
    Full story
  • 7th Crystal Structure Prediction Blind Test brings new challenges for computational chemists

    Oct 28, 2020, 07:02 AM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 28, 2020 - Announcing the new challengeThis week the 7th CSP Blind Test begins - a major challenge in computational chemistry
    Full story
  • Follow the Money: Microbiome, ‘Omics, Vaccine Patches

    Oct 28, 2020, 04:00 AM by Michael Croft
    Bio-IT World | Money for oral microbiome drugs, ‘omics, a biology plus technology transistor, digital biomarker platform, a vaccine patch that doesn’t require refrigeration, and more.
    Full story
  • Illumina Launches DRAGEN V3.7, Talks ML, Truth Challenges, All Of Us

    Oct 27, 2020, 17:58 PM by User Not Found
    Bio-IT World | Illumina is launching version 3.7 of its DRAGEN bio-IT platform this week, Rami Mehio, Vice President, Bioinformatics and Instrument Software at Illumina, told Bio-IT World last week. The newest release will include DRAGEN for Single Cell RNA, unique molecular identifier (UMI) support including UMI-aware small variant calling, CYP2D6 genotyping, and accuracy gains in both germline variant calling and tumor-only analysis.
    Full story
  • OmniTier Streamlines Personalized Medicine Workflows with CompStor Insight™ for Next-Generation Sequencing Tertiary Analysis

    Oct 27, 2020, 11:50 AM by Abhinav Singh
    MILPITAS, CA, UNITED STATES - Oct 27, 2020 - OmniTier Inc., an AI and multiomics application company whose bioinformatics solutions help deliver the promise of personalized medicine, debuted the CompStor Insight™ appliance for tertiary analysis in next-generation sequencing (NGS) applications
    Full story
  • Vidence And 2bPrecise Announce Strategic Partnership To Unleash The Power Of Genomic Data In Precision Oncology

    Oct 27, 2020, 11:24 AM by Abhinav Singh
    RALEIGH, NC, UNITED STATES - Oct 27, 2020 - Vidence, an oncology informatics company, has selected the 2bPrecise™ platform, a precision medicine data delivery solution, to make it easier for its Consortium Fellows to unlock the true power of genomic data at the point of care and facilitate the advancement of precision oncology
    Full story
  • Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience

    Oct 27, 2020, 09:48 AM by Abhinav Singh
    BOSTON, MA, UNITED STATES - Oct 27, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Baptist Health, the largest not-for-profit health system in Kentucky, has engaged the company to help elevate its digital access experience for consumers
    Full story
  • Alfa Chemistry Offers Fluorinated Building Blocks for Material, Medicinal, Agricultural, Organic Chemistry Research

    Oct 27, 2020, 00:04 AM by Abhinav Singh
    NY, NY - Oct 14, 2020 - The benefits of fluorochemistry to pharmaceutical applications are obvious and the past decades has seen increasing synthesis of fluorinated compounds in the preparation of new pharmaceuticals and agrochemicals
    Full story
  • AI & Medicine Announces Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling for Drug Discovery

    Oct 27, 2020, 00:01 AM by Abhinav Singh
    NY, NY, UNITED STATES - Oct 21, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces it now provides PK/PD modeling service to help scientists and researchers more efficiently screen drugs and thus accelerating the process of new drug development
    Full story
  • Protheragen Offers License Opportunities for Drug Development Programs

    Oct 26, 2020, 23:55 PM by Abhinav Singh
    RONKONKOMA, NY - Oct 27, 2020 - Aiming to build a bridge between academics and industry, Protheragen, a company founded in Ronkonkoma, New York, 2009, announces to offer license opportunities for drug R&D companies
    Full story
  • Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend

    Oct 26, 2020, 20:53 PM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 26, 2020 - Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding
    Full story
  • Clinical Data Visualizations at BMS Merge Trial and Real-World Data

    Oct 26, 2020, 15:55 PM by User Not Found
    Bio-IT World | The probability of success is low in early drug discovery and gets progressively more expensive on the journey to marketing approval by the Food and Drug Administration (FDA). To “fail early and fail often” has thus become the mantra of medicine developers needing to direct resources to the candidates most likely to triumph, says Philip Ross, director of translational bioinformatics data science at Bristol-Myers Squibb (BMS). Only 9.6% of drugs that make it to phase I trials ever get FDA approved.
    Full story
  • Shimmer Solicits Clinical Research Community Input on Expanded Open Wearables Initiative (OWEAR) Vision

    Oct 26, 2020, 12:49 PM by Abhinav Singh
    CAMBRIDGE, MA - Oct 26, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is evaluating a significant expansion of its vision and seeking industry input to build consensus
    Full story
  • NCH Healthcare System Partners with eVideon to Enhance Digital Patient Engagement and Education

    Oct 26, 2020, 10:55 AM by Abhinav Singh
    NEWTON, MI, UNITED STATES - Oct 26, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that NCH Healthcare System, one of the largest healthcare systems in Southwest Florida, will be implementing the company’s full suite of solutions in 576 patient rooms across its two hospitals
    Full story
  • AVIA Names Linda Finkel as CEO

    Oct 23, 2020, 11:12 AM by Abhinav Singh
    CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020
    Full story
  • BOC Sciences Lanuched A New Biotinylation Platform

    Oct 23, 2020, 00:05 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community
    Full story
  • Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study

    Oct 22, 2020, 09:32 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions
    Full story
  • «
  • 191
  • 192
  • 193
  • 194 (current)
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy